← Back

$ Value

$0

Shares

139,500

Price

$0

Filed

Mar 9

Insider

Name

Draghia-Akli Ruxandra

Title

EVP, Research & Development

CIK

0002041719

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

139,500

Footnotes

This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 5, 2026. All other information remains unchanged from the March 5, 2026 filing. | One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Filing Info

Accession No.

0001104659-26-025366

Form Type

4/A

Issuer CIK

0001000694

Draghia-Akli Ruxandra's History

Date Ticker Type Value
2026-03-03 NVAX M $0
2026-03-03 NVAX F $107K
2026-03-03 NVAX D $0
2026-03-02 NVAX A $0
2026-03-02 NVAX A $0
2025-11-11 NVAX M $0
2025-11-11 NVAX F $45K
2025-11-11 NVAX D $0

Other Insiders at NVAX (90d)

Insider Bought Sold Last
Casey Mark J
EVP, Chief Legal Officer
2026-03-03
Kelly James Patrick
EVP, CFO and Treasurer
2026-03-07
Jacobs John C
President and CEO
2026-03-03
Shiver John W. 2026-03-10
O'Hara Elaine
EVP, Chief Strategy Officer
2026-03-03
Draghia-Akli Ruxandra
EVP, Research & Development
2026-03-03
Walker Robert Edward
EVP, R&D
2026-04-14